prescription for cbd oil

2021 is giving us over-the-counter medical cannabis

Low-dose CBD cannabis oil can be sold in pharmacies from next year.

  • Facebook
  • Twitter
  • Mail
  • Whatsapp

From early 2021 you’ll technically be allowed to buy low-dose cannabis oil from pharmacies without a prescription.

However, while the laws have been changed so you can buy CBD oil over-the-counter, there are currently no products approved for sale.

Firstly, these products won’t get you high. This is only low-dose CBD oil we’re talking about and products won’t be allowed to have more than 1 per cent THC (which is the psychoactive part of the plant).

When the changes come in on February 1 next year, the maximum dose for adults will be limited to 150mg per day, which is why it’s considered low-dose. It’s expected patients would use this to help them sleep, reduce anxiety or depression and treat pain, although there’s currently not much evidence the oil is effective at this strength.

The decision from the Therapeutic Goods Administration (TGA) changes low-dose CBD oil from a schedule four drug, which doctors have to prescribe, to a schedule three drug, which chemists can hand out over-the-counter without a prescription.

Cassandra Hunt, the managing director of cannabis industry consultancy, Fresh Leaf Analytics, told Hack the change is significant.

"It’s the biggest milestone since legalisation in 2016 and it’s going to dramatically change access for patients in Australia."

She says this will make life much easier for people who want to use this drug.

“Previously, they’ve had to go to a GP and they’ve had to talk to the GP about what they’re trying to treat, and then the GP has had to get special permission in order for them to be able to access a prescription.”

There will be a wait for products

While the changes will come into effect in early 2021, it could be years before there’s actually a product to buy.

Cassandra Hunt from Fresh Leaf Analytics told Hack that it’s unlikely anything will be on the shelves in February.

“In order for companies to get these products registered or available over-the-counter in pharmacies, they have to be registered as an S3 medicine,” she said.

“What that requires is quite significant data about the safety and efficacy and quality of the products.”

According to Cassandra, because the Australian cannabis industry is still so new, they don’t know how effective their low-dose CBD products are and it could take years to get that data.

She says it’s not clear what info the TGA wants, but if it’s expecting companies to run clinical trials then it could be a five-year wait for products.

“That data, given the industry is so young, isn’t easy to come by.”

Medical Association “surprised” by down-scheduling

The Australian Medical Association (AMA) doesn’t support the TGA’s decision to down-schedule low-dose CBD oil.

In a statement to Hack, the AMA said it isn’t confident pharmacists have the education to properly advise patients, and that side effects could go unchecked.

“Medical practitioners have only been prescribing CBD products for a few years, the evidence is still emerging, more education around its use is required,” the AMA said.

When it comes to possible side effects, the medical association fears doctors won’t be able to properly monitor patients when the CBD oil is sold through pharmacies.

“There is a risk that patient conditions that are associated with CBD use (e.g. anxiety, psychosis, chronic non-cancer pain, and epilepsy) will go unchecked and cause further harm to the patient,” the AMA told Hack.

The TGA told Hack the decision to make low-dose CBD oil available over the counter wasn’t based on how well it works, just that it isn’t harmful.

“The scheduling decision was made on the basis of the safety profile of CBD at this dose,” a TGA spokesperson said.

Cassandra from Fresh Leaf Analytics admits evidence of how well these products work is hard to come by but agrees they’re not harmful.

“There is good safety data to show that at the types of doses we’re talking about CBD is very safe.”

The illicit silver lining

According to Cassandra Hunt from Fresh Leaf Analytics, the TGA could also be trying to move CBD users away from the black market.

“I think one of the other motivations of the TGA is to make it easier for people to access these products where they might otherwise be using illicit channels,” she told Hack.

"The problem with some of the illicit channels is that the quality of the products is not always good."

“Sometimes those products say they have something in them and that’s not in there, so you can’t really rely on the fact that you’re getting a good product.”

She also says that for the first time, as the cost of medical cannabis production comes down, legal products are reaching price parity with the illegal market.

“If you couple that with making it more easily accessible through pharmacies, that should hopefully make a big difference for people who’ve been getting relief through those channels, but maybe can’t rely on those products being good quality.”

CBD Oil Prescription

Cannabis medication is prescribed for a wide range of illnesses and ailments. If you are a patient, doctor, or pharmacist looking for a high quality, effective, and reliable CBD oil prescription, Cannatrek has all your needs covered.

About CBD oil and its benefits

The medical cannabis industry in Australia has been legislated by the Australian Government since 2016. Licensed businesses meet strict guidelines for establishing approved growing and production methods. Cannatrek is the Australian leading supplier of CBD oil and other medicinal cannabis products.

CBD is an active ingredient contained in cannabis. Medical CBD oil is manufactured under strict controls and doesn’t cause a psychoactive high associated with THC. CBD oil has been extensively studied for its role in addressing symptoms of many health issues such as anxiety, depression, heart disease and acne. Studies show that CBD oil is a safe and powerful treatment for wide-ranging health issues.

Conditions CBD Oil can treat

The Australian Therapeutic Goods Administration (TGA) has approved CBD oil for treating 5 primary conditions and more than 50 other medical conditions. CBD oil has proved successful in easing the symptoms of:

  • Paediatric and young adult epilepsy
  • Multiple sclerosis
  • Chronic pain
  • Nausea and vomiting associated with chemotherapy
  • Palliative care

If you suffer from any of the above, or another ailment that can be addressed with CBD oil, Cannatrek can assist. CBD oil is generally very safe to use, although some people experience side effects that include nausea, dry mouth, fatigue and drowsiness.

How to purchase CBD Oil

There is still a lot of confusion regarding purchasing CBD oil and other medical marijuana products. You may have questions regarding:

  • Finding out if you are eligible to access CBD oil
  • Finding an authorised prescriber of CBD oil
  • Getting your application approved
  • How CBD oil is prescribed
  • Cost of CBD oil in Australia
  • How much CBD oil you will need

Cannatrek cuts through the chatter to give you the answers. Cannatrek is a technology-driven Australian company with a dedication to consistently provide authentic information, education, and data related to medical marijuana products and treatments.

We provide the complete framework for patients, doctors, and pharmacists to access affordable, efficacious products via our vertical integration approach called “From Seed to Patient”. This allows us to offer:

  • Superior quality control
  • A predictive inventory
  • Greater insight into the market and demand for products
  • New product development
  • Lower production and distribution costs
  • A stable and successful market enterprise

What to consider before purchasing CBD Oil

The medicinal cannabis industry is growing incredibly fast for all the right reasons. However, along with a fast growing industry comes a degree of consumer confusion and misinformation. Here are 6 important considerations when purchasing CBD products.

  1. 1. How to pick a good brand – Choose a company that follows industry guidelines and provides comprehensive product information for making an informed choice.
  2. 2. Look for authorised products – Choose a company with a vested interest in every stage of growing and production that meets Australian Government guidelines.
  3. 3. Know what’s in the product – It’s important to read the ingredient list for CBD oil products to ensure there are no contra-indications for your specific medical condition.
  4. 4. Consider the intended CBD oil use – It can get confusing to know what’s best for your needs with so many products on the market. Target the right product with Cannatrek.
  5. 5. Consider the dosage – Look for products that display exactly how much CBD is contained in each dose. It is usually advised to start with a lower dosage, then slowly increase it.
  6. 6. Understand how it is manufactured – Choose an approved seed to patient CBD oil manufacturer who oversees every step of high quality CBD oil production.

Cannatrek CBD oil ticks all the right boxes for consistency, safety and price. We partner with authorised prescribers, medical practitioners and health professionals who understand the advantages and uses of high quality cannabis medicines.

Medicinal cannabis treatment

The Australian Government Department of Health regulates therapeutic medicines containing cannabinoids through the Therapeutic Goods Administration (TGA) and for importation or production, the Office of Drug Control.

Access is restricted to appropriate patients with medical conditions where there is evidence to support its therapeutic use.

For further information read the:

    or phone 1800 020 653 or phone (02) 6232 8740

Patients living in Queensland

A patient living in Queensland must access medicinal cannabis through a doctor who is authorised under the Special Access or Authorised Prescriber Scheme administered by the Commonwealth Therapeutic Goods Administration (TGA).

In Queensland, all doctors can prescribe Schedule 4 – cannabidiol (CBD) and Schedule 8 – tetrahydrocannabinol (THC) or tetrahydrocannabinol: cannabidiol (THC:CBD) products without a Queensland approval.

For further information read the TGA website’s Access to medicinal cannabis product page, or phone 1800 020 653.

Approvals doctors require to prescribe medicinal cannabis

Doctors require a Therapeutic Goods Administration (TGA) approval to prescribe unregistered medicinal cannabis products in Queensland. These approvals are granted under the Commonwealth Department of Health, Special Access Scheme Category B (SAS Cat B) or Authorised Prescriber Schemes. Please use TGA Online to make your application.

There are various regulatory requirements under the Medicines and Poisons (Medicines) Regulation 2021 regarding the prescribing of monitored medicines (including Schedule 8 medicinal cannabis), including prescription requirements, and compliance with relevant departmental standards.

Conditions that medicinal cannabis can be prescribed for

Queensland laws do not limit what symptoms or conditions may be applied for by your doctor. When making a TGA application the doctor will need to supply sufficient scientific evidence that supports the use of medicinal cannabis for the particular symptom or condition.

Research continues to be conducted on the potential uses of medicinal cannabis. The scientific evidence base suggests that medicinal cannabis may be suitable to treat:

  • severe muscular spasms and other symptoms of multiple sclerosis
  • chemotherapy-induced nausea and vomiting
  • some types of epilepsy with severe seizures
  • palliative care (cachexia, nausea and vomiting, pain)
  • some types of chronic non-cancer pain.

There is no evidence that medicinal cannabis is an effective primary treatment for cancer.

  • consider medicinal cannabis as an alternative treatment for cancer
  • delay starting standard cancer treatments in favour of using medicinal cannabis.


Patients are not approved to smoke cannabis as this exposes them to many of the same health risks as smoking regular cigarettes. Vaporisation using a TGA approved vaporiser is a possible alternative.

Doctors seeking approval to use a specific product will need to provide evidence of its safety and efficacy for the condition or symptom being treated to the TGA.

Participating in a clinical trial

Clinical trials are often run by pharmaceutical companies to find out about how their product behaves in patients.

Clinical trials often set entry criteria and use clinical protocols so that the results are as useful as possible. Recruitment for clinical trials is sought by a range of means including through the peak bodies for certain conditions, for example Epilepsy Queensland. Speak with your doctor to find out if there are any clinical trials for your condition.

  • Facebook
  • Twitter
  • LinkedIn

Queensland does not have amnesty for medicinal cannabis

Access to medicinal cannabis in Queensland must be for a legal product prescribed by an approved doctor and dispensed by an approved pharmacist.